Genome-wide association studies
Полногеномные ассоциативные исследования
2021-08-26
SCID: 54.1/624p69s6
Discuss with AI
clinical risk predictiongenetic correlationsgenetic variantsgenome-wide association studiesheritability estimation
Figures from the paper
Abstract (AI)
Genome-wide association studies (GWAS) test hundreds of thousands of genetic variants across many genomes to find those statistically associated with a specific trait or disease. This methodology has generated a myriad of robust associations for a range of traits and diseases, and the number of associated variants is expected to grow steadily as GWAS sample sizes increase. GWAS results have a range of applications, such as gaining insight into a phenotype’s underlying biology, estimating its heritability, calculating genetic correlations, making clinical risk predictions, informing drug development programmes and inferring potential causal relationships between risk factors and health outcomes. In this Primer, we provide the reader with an introduction to GWAS, explaining their statistical basis and how they are conducted, describe state-of-the art approaches and discuss limitations and challenges, concluding with an overview of the current and future applications for GWAS results. Uffelmann et al. describe the key considerations and best practices for conducting genome-wide association studies (GWAS), techniques for deriving functional inferences from the results and applications of GWAS in understanding disease risk and trait architecture. The Primer also provides information on the best practices for data sharing and discusses important ethical considerations when considering GWAS populations and data.
Key Findings
1
GWAS have produced numerous robust associations across diverse traits and diseases, with further discoveries expected as sample sizes increase.
2
GWAS results can illuminate phenotype biology, estimate heritability and genetic correlations, support clinical risk prediction, inform drug development, and investigate potential causal relationships.
3
Genome-wide association studies test hundreds of thousands of genetic variants across many genomes to identify variants statistically associated with traits or diseases.
4
Important challenges and limitations affect GWAS methodology and the interpretation and application of its results.
5
State-of-the-art GWAS practice includes rigorous study design, functional interpretation of associations, data sharing, and consideration of ethical issues involving populations and genetic data.
Research Object
genome-wide association studies (GWAS) of genetic variants across human genomes
Research Subject
statistical associations between genetic variants and traits or diseases, including their biological interpretation, heritability, genetic correlations, risk prediction, causal inference, applications, limitations, and ethical considerations
Publication Details
Publication Date
2021-08-26
Journal
Publisher
ISSN
Cited by
1887
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai11
A global reference for human genetic variation2015
The FAIR Guiding Principles for scientific data management and stewardship2016
The mutational constraint spectrum quantified from variation in 141,456 humans2020
A map of human genome variation from population-scale sequencing2010
An integrated map of genetic variation from 1,092 human genomes2012
The GTEx Consortium atlas of genetic regulatory effects across human tissues2020
A haplotype map of the human genome2005
METAL: fast and efficient meta-analysis of genomewide association scans2010
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease2016
A framework for enhancing ethical genomic research with Indigenous communities2018
Signatures of negative selection in the genetic architecture of human complex traits2018